LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

CHARLES SCHWAB INVESTMENT MANAGEMENT INC's Holding History (CIK: 0000884546)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 1,604,676 Value ($000) $863 Avg Close — Range —
Q4 2024
Shares 1,645,787 Value ($000) $1,053 Avg Close — Range —
Q3 2024
Shares 1,147,370 Value ($000) $1,583 Avg Close — Range —
Q2 2024
Shares 1,297,642 Value ($000) $1,882 Avg Close — Range —
Q1 2024
Shares 1,279,412 Value ($000) $2,853 Avg Close — Range —
Q4 2023
Shares 1,266,863 Value ($000) $2,458 Avg Close — Range —
Q3 2023
Shares 1,250,711 Value ($000) $1,839 Avg Close — Range —
Q2 2023
Shares 1,152,009 Value ($000) $3,663 Avg Close — Range —
Q1 2023
Shares 1,139,474 Value ($000) $2,689 Avg Close — Range —
Q4 2022
Shares 1,132,856 Value ($000) $3,931 Avg Close — Range —
Q3 2022
Shares 1,112,110 Value ($000) $8,152 Avg Close — Range —
Q2 2022
Shares 489,207 Value ($000) $3,190 Avg Close — Range —
Q1 2022
Shares 453,144 Value ($000) $2,289 Avg Close — Range —
Q4 2021
Shares 171,206 Value ($000) $1,326 Avg Close — Range —
Q3 2021
Shares 166,255 Value ($000) $2,461 Avg Close — Range —